Phase 1 Study to Evaluate DDI, PK, Safety, Tolerability of SPR741
Clinical trial NCT03376529 · COMPLETED
Trial details
- NCT number
- NCT03376529
- Sponsor
- Spero Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-10
- Primary completion
- 2017-12-19
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.